As demand for Covid vaccines falls, AstraZeneca lines up 'blockbuster' products for 2023
Publishing timestamp: 2023-02-09 07:55:34
Summary
AstraZeneca is expecting to make billions of dollars from its "blockbuster" projects in development, such as drugs to treat breast cancer, kidney disease, and a rare genetic disease. The company is on track to deliver 15 new medicines before the end of the decade and its shares have risen 5% in the morning.
Sentiment: POSITIVE
Keywords: biotech and pharmaceuticals, astrazeneca plc, business news,